Detailed information for compound 372157

Basic information

Technical information
  • TDR Targets ID: 372157
  • Name: 4-[(5S,6R)-3-(3,5-dichlorophenyl)-1-methyl-2, 4-dioxo-8-(quinolin-6-ylmethyl)-1,3,8-triazas piro[4.4]nonan-6-yl]benzonitrile
  • MW: 556.442 | Formula: C30H23Cl2N5O2
  • H donors: 0 H acceptors: 4 LogP: 5.03 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 2
  • SMILES: N#Cc1ccc(cc1)[C@@H]1CN(C[C@@]21C(=O)N(C(=O)N2C)c1cc(Cl)cc(c1)Cl)Cc1ccc2c(c1)cccn2
  • InChi: 1S/C30H23Cl2N5O2/c1-35-29(39)37(25-13-23(31)12-24(32)14-25)28(38)30(35)18-36(17-26(30)21-7-4-19(15-33)5-8-21)16-20-6-9-27-22(11-20)3-2-10-34-27/h2-14,26H,16-18H2,1H3/t26-,30+/m0/s1
  • InChiKey: MCNILTQMLDZWKD-FREGXXQWSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 4-[(5S,6R)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-8-(6-quinolylmethyl)-1,3,8-triazaspiro[4.4]nonan-6-yl]benzonitrile
  • 4-[(5S,6R)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-8-(quinolin-6-ylmethyl)-1,3,8-triazaspiro[4.4]nonan-6-yl]benzenecarbonitrile
  • 4-[(5S,6R)-3-(3,5-dichlorophenyl)-2,4-diketo-1-methyl-8-(6-quinolylmethyl)-1,3,8-triazaspiro[4.4]nonan-6-yl]benzonitrile

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Schistosoma japonicum Integrin beta-PS precursor, putative Get druggable targets OG5_127959 All targets in OG5_127959
Schistosoma japonicum Integrin beta-3 precursor, putative Get druggable targets OG5_127959 All targets in OG5_127959
Brugia malayi Integrin beta pat-3 precursor Get druggable targets OG5_127959 All targets in OG5_127959
Echinococcus multilocularis integrin beta 2 Get druggable targets OG5_127959 All targets in OG5_127959
Schistosoma japonicum ko:K06464 integrin beta 2, putative Get druggable targets OG5_127959 All targets in OG5_127959
Echinococcus granulosus integrin beta 2 Get druggable targets OG5_127959 All targets in OG5_127959
Loa Loa (eye worm) integrin beta-2 Get druggable targets OG5_127959 All targets in OG5_127959
Schistosoma mansoni integrin beta subunit Get druggable targets OG5_127959 All targets in OG5_127959

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) hypothetical protein 0.0104 0.1291 0.1876
Schistosoma mansoni serine/threonine protein kinase 0.0054 0.0462 0.0846
Schistosoma mansoni hypothetical protein 0.0043 0.0273 0.0324
Schistosoma mansoni hypothetical protein 0.0105 0.1315 0.3206
Entamoeba histolytica Niemann-Pick C1 protein, putative 0.0104 0.1291 1
Trypanosoma brucei cytochrome P450, putative 0.005 0.0381 0.2901
Echinococcus multilocularis dual specificity mitogen activated protein 0.0079 0.0872 0.1238
Loa Loa (eye worm) abnormal chemotaxis protein 14 0.0045 0.03 0.0436
Loa Loa (eye worm) integrin beta-2 0.0439 0.6881 1
Leishmania major cytochrome p450-like protein 0.005 0.0381 0.4373
Brugia malayi Kelch motif family protein 0.0069 0.0706 0.1026
Loa Loa (eye worm) hypothetical protein 0.0053 0.0434 0.0631
Brugia malayi MH2 domain containing protein 0.0126 0.1659 0.2412
Trypanosoma brucei mitogen activated protein kinase 4, putative 0.0054 0.0462 0.3513
Echinococcus multilocularis Niemann Pick C1 protein 0.0104 0.1291 0.2144
Mycobacterium ulcerans beta-ketoacyl synthase-like protein 0.0626 1 1
Brugia malayi Niemann-Pick C1 protein precursor 0.0104 0.1291 0.1876
Trypanosoma brucei RNA helicase, putative 0.0105 0.1315 1
Echinococcus granulosus integrin beta 2 0.0322 0.4919 1
Trypanosoma cruzi mitogen-activated protein kinase 11, putative 0.0054 0.0462 0.5296
Toxoplasma gondii CMGC kinase, MAPK family (ERK) MAPK-1 0.0054 0.0462 1
Trichomonas vaginalis CMGC family protein kinase 0.0054 0.0462 0.2825
Loa Loa (eye worm) MH2 domain-containing protein 0.0126 0.1659 0.2412
Trichomonas vaginalis CMGC family protein kinase 0.0054 0.0462 0.2825
Loa Loa (eye worm) hypothetical protein 0.0069 0.0706 0.1026
Brugia malayi latrophilin 2 splice variant baaae 0.0036 0.0156 0.0227
Brugia malayi Integrin beta pat-3 precursor 0.0439 0.6881 1
Trypanosoma cruzi cytochrome P450, putative 0.005 0.0381 0.4373
Brugia malayi Cytochrome P450 family protein 0.0063 0.0603 0.0876
Trypanosoma brucei mitogen-activated protein kinase kinase 5 0.0079 0.0872 0.6633
Echinococcus multilocularis Niemann Pick C1 protein 0.0149 0.2035 0.3756
Echinococcus multilocularis protein dispatched 1 0.0051 0.0406 0.0228
Loa Loa (eye worm) kelch domain-containing protein family protein 0.0069 0.0706 0.1026
Leishmania major mitogen activated protein kinase, putative,map kinase, putative 0.0054 0.0462 0.5296
Trypanosoma cruzi mitogen activated protein kinase 2, putative 0.0054 0.0462 0.5296
Schistosoma mansoni protein kinase 0.0079 0.0872 0.1981
Loa Loa (eye worm) STE/STE7/MEK1 protein kinase 0.0079 0.0872 0.1267
Plasmodium falciparum beta-ketoacyl-ACP synthase III 0.0626 1 1
Trypanosoma brucei protein kinase, putative 0.0054 0.0462 0.3513
Mycobacterium ulcerans 3-oxoacyl-ACP synthase 0.0626 1 1
Trypanosoma cruzi mitogen-activated protein kinase 11, putative 0.0054 0.0462 0.5296
Trichomonas vaginalis CMGC family protein kinase 0.0054 0.0462 0.2825
Loa Loa (eye worm) hypothetical protein 0.0045 0.03 0.0436
Giardia lamblia Kinase, STE STE20 0.0079 0.0872 1
Brugia malayi Cytochrome P450 family protein 0.005 0.0381 0.0554
Echinococcus granulosus Niemann Pick C1 protein 0.0104 0.1291 0.2144
Echinococcus granulosus mitogen activated protein kinase 3 0.0054 0.0462 0.035
Loa Loa (eye worm) cytochrome P450 family protein 0.005 0.0381 0.0554
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.0053 0.0434 0.0631
Echinococcus granulosus Niemann Pick C1 protein 0.0149 0.2035 0.3756
Loa Loa (eye worm) CMGC/MAPK/ERK1 protein kinase 0.0054 0.0462 0.0671
Loa Loa (eye worm) cytochrome P450 family protein 0.005 0.0381 0.0554
Brugia malayi CHE-14 protein 0.0045 0.03 0.0436
Echinococcus multilocularis mitogen activated protein kinase 0.0054 0.0462 0.035
Loa Loa (eye worm) cytochrome P450 family protein 0.0063 0.0603 0.0876
Loa Loa (eye worm) transcription factor SMAD2 0.0126 0.1659 0.2412
Brugia malayi MAP kinase sur-1 0.0054 0.0462 0.0671
Trichomonas vaginalis CMGC family protein kinase 0.0054 0.0462 0.2825
Loa Loa (eye worm) pigment dispersing factor receptor c 0.0053 0.0434 0.0631
Echinococcus multilocularis expressed conserved protein 0.0098 0.1185 0.1916
Mycobacterium ulcerans 3-oxoacyl-ACP synthase 0.0626 1 1
Brugia malayi Dual specificity mitogen-activated protein kinase kinase mek-2 0.0079 0.0872 0.1267
Loa Loa (eye worm) CYP4Cod1 0.005 0.0381 0.0554
Trichomonas vaginalis STE family protein kinase 0.0079 0.0872 1
Schistosoma mansoni integrin beta subunit 0.0253 0.3769 1
Wolbachia endosymbiont of Brugia malayi 3-oxoacyl-ACP synthase 0.0626 1 0.5
Plasmodium vivax beta-ketoacyl-acyl carrier protein synthase III precursor, putative 0.0626 1 1
Trichomonas vaginalis STE family protein kinase 0.0079 0.0872 1
Echinococcus multilocularis mitogen activated protein kinase 3 0.0054 0.0462 0.035
Echinococcus granulosus dual specificity mitogen activated protein 0.0079 0.0872 0.1238
Schistosoma mansoni hypothetical protein 0.0043 0.0273 0.0324
Loa Loa (eye worm) hypothetical protein 0.0036 0.0156 0.0227
Schistosoma mansoni hypothetical protein 0.0043 0.0273 0.0324
Loa Loa (eye worm) hypothetical protein 0.0055 0.0468 0.068
Trypanosoma cruzi mitogen-activated protein kinase kinase 5 0.0079 0.0872 1
Trypanosoma cruzi cytochrome P450, putative 0.005 0.0381 0.4373
Brugia malayi hypothetical protein 0.0069 0.0706 0.1026
Trypanosoma cruzi mitogen activated protein kinase 4, putative 0.0054 0.0462 0.5296
Mycobacterium tuberculosis 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) 0.0626 1 0.5
Echinococcus granulosus expressed conserved protein 0.0098 0.1185 0.1916
Loa Loa (eye worm) hypothetical protein 0.0027 0.0007 0.001
Brugia malayi Calcitonin receptor-like protein seb-1 0.0053 0.0434 0.0631
Leishmania major mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 0.0054 0.0462 0.5296
Schistosoma mansoni patched 1 0.0045 0.03 0.0399
Leishmania major mitogen-activated protein kinase kinase 5, putative;with=GeneDB:LmxM36.0860 0.0079 0.0872 1
Brugia malayi Cytochrome P450 family protein 0.005 0.0381 0.0554
Schistosoma mansoni niemann-pick C1 (NPC1) 0.0106 0.1317 0.3214
Schistosoma mansoni hypothetical protein 0.0043 0.0273 0.0324
Echinococcus granulosus mitogen activated protein kinase 0.0054 0.0462 0.035
Trichomonas vaginalis STE family protein kinase 0.0079 0.0872 1
Echinococcus multilocularis integrin beta 2 0.0322 0.4919 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (functional) = 6 nM Inhibition of LFA1-mediated adhesion of T cell to HUVEC ChEMBL. 17125246
IC50 (functional) = 6 nM Inhibition of LFA1-mediated adhesion of T cell to HUVEC ChEMBL. 17125246

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.